2-Chloro-4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine is a complex organic compound characterized by its unique bicyclic structure that incorporates both a thieno and a diazepine moiety. This compound features multiple functional groups, including chloro and methyl substituents, which can influence its chemical reactivity and biological activity. The presence of the triazole ring contributes to its potential pharmacological properties, making it of interest in medicinal chemistry. Typically, compounds of this nature may exhibit a range of biological activities, including anti-inflammatory, anticonvulsant, or anxiolytic effects, although specific activity would depend on further empirical studies. The molecular structure suggests potential interactions with various biological targets, which could be explored for therapeutic applications. Additionally, the compound's solubility, stability, and reactivity would be influenced by its substituents and overall molecular geometry, making it a candidate for further research in drug development and synthesis.

Clotizolam  is an analytical reference standard categorized as a thienotriazolodiazepine.
1
This product is intended for research and forensic applications.

2-chloro-4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine

54123-06-7: 2-Chloro-4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine is a complex organic compound characterized by its unique bicyclic structure that incorporates both a thieno and a diazepine moiety. This compound features multiple functional groups, including chloro and methyl substituents, which can influence its chemical reactivity and biological activity. The presence of the triazole ring contributes to its potential pharmacological properties, making it of interest in medicinal chemistry. Typically, compounds of this nature may exhibit a range of biological activities, including anti-inflammatory, anticonvulsant, or anxiolytic effects, although specific activity would depend on further empirical studies. The molecular structure suggests potential interactions with various biological targets, which could be explored for therapeutic applications. Additionally, the compound's solubility, stability, and reactivity would be influenced by its substituents and overall molecular geometry, making it a candidate for further research in drug development and synthesis.

<p>Clotizolam is a thienotriazolodiazepine derivative with PAF antagonistic properties, exhibiting sedative, anxiolytic, anticonvulsant, and muscle relaxant effects.</p>

CAS 54123-06-7

2-chloro-4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine

Clotizolam

Ref: TM-T203541